Startup profile for Hopscotch Primary Care: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Hopscotch Primary Care funding, valuation and investors

Tech-enabled primary care clinics for rural communities in the Southeastern United States.

Keep track of Hopscotch Primary Care

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series D

$53M · August 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$53M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Chicago, Illinois

Investors in latest funding

Lead: 8VC , Town Hall Ventures

Sources: latest funding Last verified: 2026-08-25

Overview

Hopscotch Primary Care operates technology-enabled primary care clinics serving rural communities, with same-day access and care teams supported by proprietary software. On August 18, 2026 it announced a $53 million Series D led by 8VC and Town Hall Ventures, with participation from aMoon, Citi Impact Fund, Alumni Ventures, K2 HealthVentures, and new investors including the Autism Impact Fund, John Doerr, Dr. Richard Merkin, and the Leon Levine Foundation. The company reports more than 15,000 patients across 10+ clinical locations, densest in rural Western North Carolina.

Why Hopscotch Primary Care is interesting

August 2026 Series D ($53M) co-led by 8VC and Town Hall Ventures — clinic ops as the product for 15,000+ rural patients, not another telehealth app.

Product & use cases

Rural primary care clinics with same-day access and technology that supports care teams beyond clinic walls.

  • Primary care access in rural provider deserts
  • Same-day acute and chronic care visits
  • Care coordination extending beyond the clinic visit

Key facts

  • Series D (Aug 18, 2026): $53M led by 8VC and Town Hall Ventures (PR Newswire)
  • 15,000+ patients; 10+ clinics; rural Western NC concentration
  • Use of proceeds: deepen Southeast access, new rural markets, tech-powered ops

Funding history (newest first)

Investors in our directory

Funds linked from Hopscotch Primary Care's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Clinic footprint plus rural-focused ops tech — solving geography, not only insurance UX.

Hopscotch underwrites as a multi-site care delivery business. Provider recruiting and Medicaid/commercial mix dominate unit economics versus SaaS multiples.

  • Pure telehealth platforms adjacent

    Lower CapEx; weaker for exam-heavy primary care.

  • Urban DPC / One Medical-style models adjacent

    Different geography and payer mix.

  • Hospital outpatient clinics incumbent

    Broader specialty presence; often slower primary access.

Notable stories

  • Corrected PR Newswire release lists John Doerr and Dr. Richard Merkin among new Series D participants (Aug 18, 2026).

Industries

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover Hopscotch Primary Care's financing or category context.

FAQs about Hopscotch Primary Care

Practical answers founders, operators, and investors typically search for.

Hopscotch runs tech-enabled primary care clinics for rural patients in the Southeastern U.S.
Series D (Aug 2026, $53M) led by 8VC (/fund/8vc) and Town Hall Ventures.
Growth-stage private company after Series D August 2026.
More than 15,000 rural patients across Southeastern clinic locations (company).
Hopscotch is an in-person clinic operator with software support — not a pure virtual care app.
Private as of August 2026.
Company announces from Chicago; clinics concentrated in the rural Southeast.
Not publicly disclosed.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.